---
title: "Pharscin Pharma: Cang Er Zi Nasal Inflammation Capsules have completed domestic drug filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247464777.md"
description: "Pharscin Pharma announced that its product Cang'erzi Rhinitis Capsules has completed the domestic production drug filing"
datetime: "2025-07-07T09:38:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247464777.md)
  - [en](https://longbridge.com/en/news/247464777.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247464777.md)
generator: "portal-rs"
---

# Pharscin Pharma: Cang Er Zi Nasal Inflammation Capsules have completed domestic drug filing

Pharscin Pharma announced that its product Cang'erzi Rhinitis Capsules has completed the domestic production drug filing

### Related Stocks

- [002907.CN](https://longbridge.com/en/quote/002907.CN.md)

## Related News & Research

- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [FLU: Profit and EBITDA up on Malta growth and cost cuts, with 2026 guidance raised](https://longbridge.com/en/news/296306424.md)
- [Ximei Resources clarifies tantalum pricing mechanism in Ganfeng Lithium procurement deal](https://longbridge.com/en/news/296362749.md)
- [Innventure directors force management, board to forfeit Accelsius earnout shares tied to DarkNX order](https://longbridge.com/en/news/296352522.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**